US · KLTO
Klotho Neurosciences, Inc.
- Sector
- Healthcare · Biotechnology
- Headquarters
- Omaha, NE 68144
- Website
- klothoneuro.com
Price · as of 2026-04-14
$0.35
Market cap 28.02M
Price history
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | $10.24 | ||||
| 2023 | $10.53 | ||||
| 2024 | $0.29 |
About Klotho Neurosciences, Inc.
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.
- CEO
- Joseph Sinkule
- Employees
- 3
- Beta
- 2.48
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Growth | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| KLTO | Klotho Neurosciences, Inc… | $0.38 | 28.02M | — | — | -0.90 | 4.69 | — | -1.00 | — |
| CVKD | Cadrenal Therapeutics, In… | $8.49 | 19.85M | — | — | -1.11 | 5.39 | — | -0.80 | — |
| IBIO | iBio, Inc. | $2.82 | 44.53M | — | — | -0.48 | 0.59 | 22.05 | -0.22 | 77.78% |
| MTVA | MetaVia Inc. | $1.51 | 3.32M | — | — | -0.22 | 0.53 | — | 0.53 | — |
| NERV | Minerva Neurosciences, In… | $6.60 | 46.15M | — | — | -0.23 | -0.47 | — | -0.17 | — |
| NRSN | NeuroSense Therapeutics L… | $0.91 | 22.42M | — | — | -1.97 | -14.03 | — | -1.98 | — |
| RLYB | Rallybio Corporation | $7.54 | 39.81M | — | — | -5.96 | 0.92 | 62.33 | 0.04 | 34.91% |
| SONN | Sonnet BioTherapeutics Ho… | $1.26 | 8.43M | — | — | -0.19 | -2.83 | 73.88 | -0.12 | -87.40% |
| TAOX | TAO Synergies Inc. | $3.91 | 13.63M | — | — | -0.65 | 0.85 | 62.24 | -1.45 | — |
| XCUR | Exicure, Inc. | $3.74 | 23.84M | — | — | -5.35 | 6.74 | — | -2.37 | -100.00% |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.35) − 1 = — (IC, example).